Description and Brand Names
药物信息提供方：IBM Micromedex
US Brand Name
- Ocaliva
Descriptions
Obeticholic acid is used alone or in combination with ursodeoxycholic acid (UDCA) to treat primary biliary cholangitis (PBC) without liver problems (eg, cirrhosis) or with compensated cirrhosis but do not have portal hypertension (increased pressure in the portal vein) in patients who have received UDCA but did not work well.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2022
版权 © 2020 IBM Watson Health。保留所有权利。信息仅供终端用户使用，不得出售、重新分发或用于其他商业目的。